Gross Profit On Sales تغییر دادن تاریخ
Acadia Pharmaceuticals USD 223.92M 13.87M 2025-03
Alnylam Pharmaceuticals USD 523.15M 32.8M 2025-03
Amgen USD 5.54B 430M 2025-03
Biogen USD 1.8B 69.5M 2025-03
BioMarin Pharmaceutical USD 593.59M 17.59M 2025-03
Cytokinetics -160545000 81.19M 2024-09
Daiichi Sankyo JPY 424.35B 67.89B 2025-03
Gilead Sciences USD 5.99B 17M 2024-12
Incyte USD 1.14B 151.67M 2025-06
Ionis Pharmaceuticals USD 448M 317.85M 2025-06
Ironwood Pharmaceuticals USD 3.65M 60.36M 2024-09
Novartis USD 11.51B 1.12B 2025-06
Pfizer USD 11.12B 987M 2025-03
PTC Therapeutics USD 196.89M 10.95M 2024-12
Roche Holding CHF 11.69B 48M 2024-12
Sarepta Therapeutics USD 607.29M 81.18M 2025-03
TG Therapeutics USD 92.79M 18.25M 2024-12
Ultragenyx Pharmaceutical USD 110.63M 37.35M 2025-03
Vertex Pharmaceuticals USD 2.49B 109.3M 2024-12
Xencor 32.73M 77.88M 2025-03


PTC Therapeutics سود ناخالص در فروش - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Aug 2025.